SMP-028 Nasal Allergen Challenge Study

• Research type

  Research Study

• Full title

  An exploratory, randomised, double blind, placebo-controlled, 14 day, three-way crossover study, followed by an open label 1 day period when subjects will be dosed with intranasal fluticasone, nasal allergen challenge (NAC) study to evaluate the effects of SMP-028 on the release of inflammatory mediators after NAC with Timothy grass pollen in subjects with allergic rhinitis out of season.

• IRAS ID

  25467

• Contact name

  Brian Leaker

• Contact email

  brian.leaker@heartlungcentre.com

• Sponsor organisation

  Dannippon Sumitimo Pharma

• Eudract number

  2009-012674-12

• ISRCTN Number

  Not submitted

• Research summary

  Research Summary not published at request of researcher

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  09/H0720/110

• Date of REC Opinion

  14 Oct 2009

• REC opinion

  Further Information Favourable Opinion